Emerging Business Models in Biopharma - Drug Discovery TOE

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This edition of the Drug Discovery TOE depicts the current landscape and the new life sciences trends across emerging business models in the biopharmaceutical industry. The corresponding patent scenario is depicted, along with the industry interactions..

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Biopharma, proof of concept model, lean innovation model, outcome focused model, collaborative business model

Table of Contents

Emerging Business Models in Biopharma - Drug Discovery TOETrend OverviewEmerging Business Models in BiopharmaEmerging Business Models in BiopharmaTechnology ProfilesProof of Concept ModelValue Enabling Model Lean Innovation ModelOutcome Focused Model Collaborative Business ModelOutcome Focused ModelCollaborative Business ModelStrategic InsightsTrends Transforming the Healthcare Value ChainStrategies Driving Biopharma EvolutionAppendixPatent AnalysisPatent AnalysisIndustry InteractionsIndustry Interactions




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.